English  |  正體中文  |  简体中文  |  Items with full text/Total items : 21921/27947 (78%)
Visitors : 4216452      Online Users : 361
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: http://140.128.103.80:8080/handle/310901/27923


    Title: Lactate dehydrogenase, not vascular endothelium growth factor or basic fibroblast growth factor, positively correlates to bone marrow vascularity in acute myeloid leukemia.
    Authors: 黃光裕
    Teng, Chieh-Lin
    Young, Ji-Hsiung
    Hsu, Shih-Lan
    Chou, Guan
    Kuo, Ing-Tiau
    Yu, Chen-Yuan
    Hwang, Guang-Yuh
    Contributors: Taichung Veterans General Hospital
    Department of Life Sciences, Tunghai University
    Taipei Veterans General Hospital
    Keywords: acute myeloid leukemia
    angiogenesis
    basic fibroblast growth factor
    lactate dehydrogenase
    vascular endothelial growth factor
    Date: 2006-11
    Issue Date: 2016-08-17T01:30:08Z (UTC)
    Publisher: 荷蘭:Elsevier
    Abstract: Background: Angiogenesis has been extensively studied in acute myeloid leukemia (AML). Lactate dehydrogenase (LDH),
    a common biochemical marker for tumor burden and anaerobic glycolysis, is a poor prognostic factor for AML. Regulated by
    hypoxia-induced factor, both vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) are responsive
    to cancer-related angiogenesis. To study the roles of serum LDH, VEGF and bFGF in AML angiogenesis, we investigated
    bone marrow vascularity in untreated AML patients, and analyzed its relationship to serum LDH, VEGF and bFGF levels.
    Methods: Eighteen (11 males, 7 females; mean age, 57.7 years) de novo, untreated AML patients were enrolled. Bone
    marrow vascularity was evaluated by staining bone marrow core biopsy tissue with endothelial cell marker CD31 or
    CD34. Serum LDH was determined with the Wroblewski-La Due method. Serum VEGF and bFGF were determined with
    enzyme-linked immunoassay. The relationship of LDH, VEGF and bFGF level to bone marrow vessel numbers was examined
    by linear regression.
    Results: Log LDH significantly correlated to AML bone marrow vascularity (r = 0.61; p = 0.007). VEGF and bFGF concentrations
    did not correlate with AML angiogenesis.
    Conclusion: These results suggest that serum LDH, but not VEGF and bFGF concentrations, can be used as a simple
    parameter for predicting vessel formation in AML bone marrow.
    Relation: Journal of the Chinese Medical Association, 69(11), 534-537
    Appears in Collections:[生命科學系所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML141View/Open


    All items in THUIR are protected by copyright, with all rights reserved.


    本網站之東海大學機構典藏數位內容,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback